- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT02164383
A Quit Smoking Study Using Smartphones
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Studientyp
Einschreibung (Tatsächlich)
Phase
- Unzutreffend
Kontakte und Standorte
Studienorte
-
-
Wisconsin
-
Madison, Wisconsin, Vereinigte Staaten, 53711
- University of Wisconsin Center for Tobacco Research and Intervention, School of Medicine and Public Health
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- being age 18 or older;
- being able to read and write English;
- being willing and able to learn how to use a smartphone if they have not used one before;
- smoking 10 or more cigarettes per day for the past 6 months;
- having an expired carbon monoxide rating of 6 ppm or greater;
- not having been diagnosed with or treated for schizophrenia, psychosis or bipolar disorder in the past 10 years;
- being willing to make a quit attempt in 2 weeks;
- agreeing to attend clinic visits, receive coaching calls, and complete brief smartphone assessments;
- planning to remain in the area for at least the next 2 months;
- using the following alternative tobacco products (a pipe, full sized cigars, snuff or chew) no more than two times a week over the past month;
- being willing to stop using electronic cigarettes (e-cigarettes) for the 6 weeks they are in the study;
- not currently taking bupropion, Wellbutrin, or Zyban;
- if currently using nicotine replacement therapy or Varenicline, agreeing to use only study medication for the duration of the study;
- being willing and able to use the nicotine patch;
- never having had a serious skin reaction or other allergic reaction to the nicotine patch;
- not pregnant, trying to conceive, or nursing;
- if a woman of childbearing potential, agreeing to use or having their partner use an acceptable method of birth control during a 2 month period (1 month of nicotine patch and 1 month after). (Acceptable methods of birth control include: abstinence, condoms, diaphragm, birth control pills or injectable contraceptive [e.g., Depo-Provera], an intrauterine device, hysterectomy, tubal ligation, sterilization, vasectomy, or being more than 2 years post-menopausal.)
- Participants need to report playing video games for no more than 60 minutes a day.
- Although participants can play console games, they need to be willing to not play any mobile games for 6 weeks during the study if they are asked to do so.
- Participants need to report being willing to stay in the study even if they are not at first successful in quitting smoking.
- They need to report that they have a way to get to the clinic.
Exclusion Criteria:
- They will be excluded if in the last 4 weeks they have been hospitalized for any of the following: a stroke, heart attack, congestive heart failure, or an abnormal electrocardiogram.
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Behandlung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Single
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: Mobile Games
This arm of the project will address the following question: How effective is the following intervention? Nicotine patch plus behavioral cessation counseling with access to Mobile Games. |
4-week starter kit of nicotine patch
5 brief counseling sessions
|
|
Experimental: No Mobile Games
This arm of the project will address the following question: How effective is the following intervention: Nicotine patch plus behavioral cessation counseling without access to Mobile Games. |
4-week starter kit of nicotine patch
5 brief counseling sessions
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Change Between Baseline Mean Cigarettes Smoked Per Day and Mean Cigarettes Smoked Per Day During the First 4 Weeks of the Quit Attempt Calculated as Percentage Change
Zeitfenster: Cigarettes per day measured daily for the first 4 weeks of the quit attempt (starting on the target quit day) and at baseline
|
Every day participants will report the number of cigarettes they smoked that day at baseline and for the first 4 weeks of the quit attempt (starting on the target quit day) using timeline followback assessment.
This information will be used to calculate a participant's change in mean cigarettes smoked per day from baseline compared to the mean across the first 4 weeks of the quit attempt calculated as percentage change.
|
Cigarettes per day measured daily for the first 4 weeks of the quit attempt (starting on the target quit day) and at baseline
|
Mitarbeiter und Ermittler
Sponsor
Mitarbeiter
Ermittler
- Hauptermittler: Tanya R. Schlam, PhD, University of Wisconsin Center for Tobacco Research and Intervention
Publikationen und hilfreiche Links
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn
Primärer Abschluss (Tatsächlich)
Studienabschluss (Tatsächlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Schätzen)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
- Psychische Störungen
- Chemisch induzierte Störungen
- Substanzbezogene Störungen
- Tabakkonsumstörung
- Physiologische Wirkungen von Arzneimitteln
- Neurotransmitter-Agenten
- Molekulare Mechanismen der pharmakologischen Wirkung
- Autonome Agenten
- Agenten des peripheren Nervensystems
- Cholinerge Wirkstoffe
- Ganglionäre Stimulanzien
- Nikotin-Agonisten
- Cholinerge Agonisten
- Nikotin
Andere Studien-ID-Nummern
- 2013-1606
- P50CA143188 (US NIH Stipendium/Vertrag)
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .